Clinical trial
Use of RDS MultiSense® in Post-ICU Patients in the COVID-19 Era
NCT04661423 is registered in ClinicalTrials.gov with IHU Strasbourg as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Use of RDS MultiSense® in Post-ICU Patients in the COVID-19 Era
- Lead sponsor
- IHU Strasbourg
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- September 2, 2021
- Completion date
- March 2, 2025
- Enrollment
- 60 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
post icu rehabilitation